127 related articles for article (PubMed ID: 2894124)
1. Epidemiology and pathophysiology of tardive dyskinesias.
Klawans HL; Tanner CM; Goetz CG
Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
[No Abstract] [Full Text] [Related]
2. [Tardive dyskinesias. Epidemiology and physiopathology].
Gerlach J
Ugeskr Laeger; 1987 Jun; 149(25):1678-81. PubMed ID: 2885954
[No Abstract] [Full Text] [Related]
3. Prevalence of tardive dyskinesia.
Tepper SJ; Haas JF
J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
Ezrin-Waters C; Seeman MV; Seeman P
J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
[TBL] [Abstract][Full Text] [Related]
5. [Tardive dyskinesias].
Mignot G
Encephale; 1983; 9(2):151-66. PubMed ID: 6139271
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced tardive dyskinesia.
Jenner P; Marsden CD
Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
9. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
Jenner P; Marsden CD
Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
[No Abstract] [Full Text] [Related]
10. Drug therapy of tardive dyskinesia.
Kobayashi RM
N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
[No Abstract] [Full Text] [Related]
11. Drug-induced movement disorders.
Gershanik OS
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
[TBL] [Abstract][Full Text] [Related]
12. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
Olajossy M
Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766
[No Abstract] [Full Text] [Related]
13. Epidemiology of tardive dyskinesia in the elderly.
Blowers AJ
Neuropharmacology; 1981 Dec; 20(12B):1339-40. PubMed ID: 6119647
[No Abstract] [Full Text] [Related]
14. Tardive dyskinesia in mentally retarded children, adolescents, and young adults: North Carolina and Michigan studies.
Gualtieri CT; Breuning SE; Schroeder SR; Quade D
Psychopharmacol Bull; 1982 Jan; 18(1):62-5. PubMed ID: 6152872
[No Abstract] [Full Text] [Related]
15. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
16. [Tardive dyskinesia and affective disorders].
Azorin JM; Thermoz P
Encephale; 1988; 14(5):359-63. PubMed ID: 2905642
[TBL] [Abstract][Full Text] [Related]
17. [What is the connection between Parkinson disease and tardive dyskinesia?].
Gunne LM; Andrén PE
Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538
[No Abstract] [Full Text] [Related]
18. Tardive dyskinesia.
Gerlach J
Dan Med Bull; 1979 Aug; 26(5):209-45. PubMed ID: 40756
[No Abstract] [Full Text] [Related]
19. Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.
Kalachnik JE; Harder SR; Kidd-Nielsen P; Errickson E; Doebler M; Sprague RL
Psychopharmacol Bull; 1984; 20(1):27-32. PubMed ID: 6144132
[No Abstract] [Full Text] [Related]
20. Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection.
Gibson AC
Acta Psychiatr Scand Suppl; 1981; 291():111-6. PubMed ID: 6113729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
